LAILA
LIVE

Serial Number

99231504

Owner

Lila Biologics, Inc.

Attorney

John Paul Oleksiuk

Filing Date

Jun 12, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LAILA Trademark

Serial Number: 99231504

LAILA is a trademark filed by Lila Biologics, Inc. on June 12, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Lila Biologics, Inc. (3 trademarks)

1616 Eastlake Avenue East
Seattle, WA 98102

Entity Type: 03

Trademark Details

Filing Date

June 12, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for detecting and treating cancer, infectious diseases, inflammation, fibrosis, hypertension, cardiovascular disease, chronic obstructive pulmonary disease, obesity, and musculoskeletal diseases; Pharmaceutical peptide and protein compositions for detecting and treating cancer, infectious diseases, inflammation, fibrosis, hypertension, cardiovascular disease, chronic obstructive pulmonary disease, obesity, and musculoskeletal diseases; Protein arrays for medical diagnosis purposes; Pharmaceutical preparations in the nature of therapeutic proteins for use in the detection and treatment of human diseases

scientific research in the field of proteomics; pharmaceutical drug development services; pharmaceutical research services; provision of information and data relating to medical and pharmaceutical research and development; medical research; biological research

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 30, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 30, 2026 GNSL
SUSPENSION LETTER WRITTEN
Apr 30, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 23, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 23, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 1, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 1, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 1, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 1, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 19, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 12, 2025 MAFR
NEW APPLICATION ENTERED
Jun 12, 2025 NWAP